PGGT1B and pancreatic neoplasm: We further extend the use of liposomal GGTI for cancer therapy by demonstrating that liposomal-GGTI can be combined with farnesyltransferase inhibitor (FTI) to inhibit K-Ras signaling in pancreatic cancer cells.